Canopy Growth Corporation (CGC) vs Relmada Therapeutics, Inc. (RLMD)
A side-by-side comparison of Canopy Growth Corporation and Relmada Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGC
Canopy Growth Corporation
$0.89HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT
RLMD
Relmada Therapeutics, Inc.
$3.33HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
Total return — CGC vs RLMD
growth of $100 · dividends reinvested · last 10yCGC -97.6% (-31.2%/yr)RLMD +200.0% (+11.6%/yr)RLMD compounded faster over this window
Log scale — wide-divergence pair
CGC RLMD
CGC vs RLMD: by the numbers
- •CGC is the larger company ($374M vs $349M market cap).
- •Both run net losses; RLMD's is the smaller (0.00% vs -81.04% net margin).
Metrics side by side
Valuation
| Metric | CGC | RLMD |
|---|---|---|
| P/S ratio | 1.62 | N/A |
| P/B ratio | 0.77 | 1.69 |
Profitability
| Metric | CGC | RLMD |
|---|---|---|
| Gross margin | 25.47% | 0.00% |
| Operating margin | -31.98% | 0.00% |
| Net margin | -81.04% | 0.00% |
| ROE | -38.57% | -29.98% |
| ROIC | -10.85% | -30.78% |
Growth (annualized)
| Metric | CGC | RLMD |
|---|---|---|
| Revenue CAGR (5Y) | -12.47% | N/A |
| Total return CAGR (5Y) | -63.36% | -7.68% |
Frequently asked
- How have CGC and RLMD total returns compared?
- Over the past 10 years, CGC delivered -31.35% and RLMD delivered 12.41% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.